Literature DB >> 8784564

Detection of a transforming fragment of herpes simplex virus type 2 in clinical specimens by PCR. The Canadian Women's HIV Study Group.

G H Guibinga1, F Coutlée, A Kessous, C Hankins, N Lapointe, G Richer, J Tousignant.   

Abstract

A PCR assay for the sensitive detection of a transforming fragment of herpes simplex virus type 2 (HSV-2) was developed. Oligonucleotide primers were selected in Xho-2, a transforming region of the BglII N fragment of HSV-2. The assay reached a sensitivity endpoint of 10 copies of the Xho-2 subfragment and did not show cross-reactivity with other herpesviruses, including HSV-1. All 42 HSV-2 isolates scored positive in the assay. The Xho-2 PCR assay was evaluated with 216 clinical specimens and the results were compared with those of cell culture. The best protocol for processing specimens contained in viral transport medium included a centrifugation step followed by cell lysis. Of the 107 specimens positive for HSV-2 by culture, 105 were PCR positive (sensitivity, 98.1%). For one of the two falsely negative samples, beta-globin as well as sequences from the HSV-2 DNA polymerase gene could not be amplified. The other sample scored positive in both of these reactions but was indeterminate in duplicate tests by Xho-2 PCR. Two of 109 HSV-2 culture-negative specimens tested positive in the PCR assay (specificity, 98.2%). The latter two samples tested positive in a PCR test for the HSV-2 DNA polymerase gene. This novel tool was shown to be sensitive and specific for HSV-2 sequences and should allow for the investigation of the role of HSV-2 in genital cancers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784564      PMCID: PMC229089     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Rapid DNA diagnosis of herpes simplex virus serotypes.

Authors:  T Matsumoto; O Yamada; A Itagaki; S Ishida; T Kamahora; T Kurimura
Journal:  J Virol Methods       Date:  1992-10       Impact factor: 2.014

2.  Small fragments of herpesvirus DNA with transforming activity contain insertion sequence-like structures.

Authors:  D A Galloway; J A Nelson; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

3.  One-step determination of herpes simplex virus types I and II by polymerase chain reaction.

Authors:  C Shimizu; H Shimizu; T Mitsuda; M Tsukuda; S Ichikawa; S Yokota
Journal:  Mol Cell Probes       Date:  1994-06       Impact factor: 2.365

4.  Characterization of mRNAs that map in the BglII N fragment of the herpes simplex virus type 2 genome.

Authors:  F J Jenkins; M K Howett
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

5.  The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism.

Authors:  D A Galloway; J K McDougall
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

6.  Identification of proteins encoded by a fragment of herpes simplex virus type 2 DNA that has transforming activity.

Authors:  D A Galloway; L C Goldstein; J B Lewis
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

Review 7.  Cervical cancer: is herpes simplex virus type II a cofactor?

Authors:  C Jones
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

8.  Differentiation of herpes simplex virus 1 and 2 in cerebrospinal fluid of patients with HSV encephalitis and meningitis by stringent hybridization of PCR-amplified DNAs.

Authors:  H Shoji; M Koga; T Kusuhara; M Kaji; M Ayabe; H Hino; R Hondo
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

9.  Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women.

Authors:  R W Cone; A C Hobson; Z Brown; R Ashley; S Berry; C Winter; L Corey
Journal:  JAMA       Date:  1994-09-14       Impact factor: 56.272

10.  Transformation of rodent cells by a cloned DNA fragment of herpes simplex virus type 2.

Authors:  D A Galloway; J K McDougall
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.